Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 3 2Phase 4 1Phase 2 1

Status

Completed 2Terminated 1Recruiting 1Enrolling by invitation 1Active not recruiting 1

Sponsor Class

OTHER 6

Study Type

Interventional 6

Sponsor

Cancer Type

Breast 2Other 1Head & Neck 1Gastrointestinal 1CNS 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1Persistent Postoperative Pain 1Obesity 1Mouth Neoplasms 1Liver Neoplasms 1Inflammation 1Breast Neoplasms 1Breast Cancer Patient 1Brain Neoplasms 1

Interventions

pembrolizumab 1265Specimen Handling 926Magnetic Resonance Spectroscopy 830Carboplatin 823Cyclophosphamide 800Cisplatin 723Nivolumab 669Paclitaxel 627Radiotherapy 611Gemcitabine 573Biopsy 557Bevacizumab 478Dexamethasone 438fludarabine 407Docetaxel 380venetoclax 368Oxaliplatin 364Capecitabine 358Fluorouracil 355atezolizumab 350durvalumab 332Rituximab 330Drug Therapy 326Doxorubicin 316Radiosurgery 315Standard of Care 309Blood Specimen Collection 308Pemetrexed 305Ipilimumab 299Radiation 286

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

6 trials
RecentStart dateEnrollment
Pregabalin × 1 year × Clear all
NCT07630753 2026-06-05

Effect of Pregabalin on Optic Nerve Sheath Diameter in Craniotomy Patients.

Benha University

Phase NA Active not recruiting
100 enrolled
CNS

Brain Neoplasms

NCT07606638 2026-05-26

Effectiveness of Opioid vs Pregabalin Plus Naproxen Sodium in Pain Management of Oral Cancer Patients

Mayo Hospital Lahore

Phase NA Enrolling by invitation
98 enrolled
Head & Neck

Squamous Cell Carcinoma of Head and Neck, Mouth Neoplasms

NCT03794388 2026-05-05

CAPTRANE

Institut Cancerologie de l'Ouest

Phase 3 Completed
140 enrolled 6 charts
Breast

Breast Cancer Patient

NCT03151213 2026-03-13

pregabalin

Tanta University

Phase 4 Completed
70 enrolled
Gastrointestinal

Liver Neoplasms

NCT03216187 2025-10-07

PREVENT

University Hospital, Geneva

Phase 3 Terminated
126 enrolled

Persistent Postoperative Pain

NCT06150898 2025-06-13

KePreSt

Jules Bordet Institute

Phase 2 Recruiting
112 enrolled
BreastOther

Breast Neoplasms, Inflammation, Obesity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡